Harrow says IHEEZO trial shows 58% lower discomfort than proparacaine after intravitreal injections

Harrow reported new clinical study results for IHEEZO, an ocular anesthetic gel used during intravitreal injections.

• Findings were announced now, with no indication of a future conference presentation.
• Patients in a bilateral-eye study reported less post-injection discomfort with IHEEZO versus a commonly used legacy anesthetic.
• Benefit was consistent across multiple post-procedure time checks, strongest soon after injection, supporting broader adoption in high-volume retina practices.